Director of the BOD; CTO
With over 30 years of biotech experience, Mr. Palahnuk has demonstrated high-level leadership in process development, MST, technology transfer, and technical operations oversight. He founded and led MST or PD departments at Samsung Biologics, TopAlliance, ImClone/Eli Lilly, and Bio-Thera, where he managed TT and supported registration for ipilimumab, rituximab, nivolumab, and several other novel therapeutics. He also held engineering positions at global companies including Hoffmann-La Roche, Procter and Gamble, and Takeda. He has an M.S. in Chemical Engineering from Lehigh University.